MiRNA expression profiling in migrating Glioblastoma cells: Regulation of cell migration and invasion by miR-23b via targeting of Pyk2

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Loftus, Joseph C ^a   Ross, Julianna T D ^b   Paquette, Kimberly M ^b   Paulino, Vincent M ^b   Nasser, Sara ^b   Yang, Zhongbo ^a   Kloss, Jean ^a   Kim, Seungchan ^b   Berens, Michael E ^b   Tran, Nhan L ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 2; MICRORNA; MICRORNA 23B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; CELL MOVEMENT; FOCAL ADHESION KINASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MICRORNAS;

EID: 84862705620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039818     Document Type: Article

References (47)

1. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, et al. (2001) Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol 53: 161-176.
2. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, et al. (2003) Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116: 4409-4417.
3. Lefranc F, Rynkowski M, DeWitte O, Kiss R, (2009) Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 34: 3-35.
4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466.
5. Lefranc F, Brotchi J, Kiss R, (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 2411-2422.
6. Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, et al. (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302: 261-275.
7. Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
8. Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
9. Mischel PS, Shai R, Shi T, Horvath S, Lu KV, et al. (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22: 2361-2373.
10. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
11. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, et al. (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7: 7-16.
12. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME, (2009) NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 11: 377-387.
13. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, et al. (2008) Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9: 54.
14. Liu N, Okamura K, Tyler DM, Phillips MD, Chung WJ, et al. (2008) The evolution and functional diversification of animal microRNA genes. Cell Res 18: 985-996.
15. Melo SA, Esteller M, (2011) Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 585: 2087-2099.
16. Asadi-Moghaddam K, Chiocca EA, Lawler SE, (2010) Potential role of miRNAs and their inhibitors in glioma treatment. Expert Rev Anticancer Ther 10: 1753-1762.
17. Lawler S, Chiocca EA, (2009) Emerging functions of microRNAs in glioblastoma. J Neurooncol 92: 297-306.
18. Novakova J, Slaby O, Vyzula R, Michalek J, (2009) MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386: 1-5.
19. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
20. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
21. Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, et al. (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93: 325-332.
22. Song L, Huang Q, Chen K, Liu L, Lin C, et al. (2010) miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun 402: 135-140.
23. Purow B, (2011) The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? J Neurooncol 103: 429-436.
24. Lipinski CA, Tran NL, Bay C, Kloss J, McDonough WS, et al. (2003) Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. Mol Cancer Res 1: 323-332.
25. Lipinski CA, Tran NL, Menashi E, Rohl C, Kloss J, et al. (2005) The tyrosine kinase Pyk2 promotes migration and invasion of glioma cells. Neoplasia 7: 435-445.
26. McDonough W, Tran N, Giese A, Norman SA, Berens ME, (1998) Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 57: 449-455.
27. Tran NL, McDonough WS, Donohue PJ, Winkles JA, Berens TJ, et al. (2003) The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol 162: 1313-1321.
28. Berens ME, Rief MD, Loo MA, Giese A, (1994) The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 12: 405-415.
29. Berens ME, Beaudry C, (2004) Radial monolayer cell migration assay. Methods Mol Med 88: 219-224.
30. Storey JD, (2002) A direct approach to false discovery rates. J Royal Statistical Society: Series B (Statistical Methodology) 64: 479-498.
31. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
32. Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME, (2005) EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol 167: 565-576.
33. Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, et al. (2006) Increased Fibroblast Growth Factor-Inducible 14 expression levels promote glioma cell invasion via Rac1 and Nuclear Factor-kB and correlate with poor patient outcome. Cancer Res 66: 9535-9542.
34. Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, et al. (2004) The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res 64: 3179-3185.
35. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
36. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
37. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
38. Gutenberg A, Bruck W, Buchfelder M, Ludwig HC, (2004) Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol (Berl) 108: 224-230.
39. Lipinski CA, Tran NL, Viso C, Kloss J, Yang Z, et al. (2008) Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts. J Neuro-Oncol 90: 181-189.
40. Moriarty CH, Pursell B, Mercurio AM, (2010) miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem 285: 20541-20546.
41. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
42. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, et al. (2009) MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J 276: 2966-2982.
43. Sun T, Yang M, Chen S, Balk S, Pomerantz M, et al. (2011) The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Prostate.
44. Zhang H, Hao Y, Yang J, Zhou Y, Li J, et al. (2011) Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2: 554.
45. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, et al. (2005) Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro-Oncol 7: 164-176.
46. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H, (2011) The brain tumor microenvironment. Glia 59: 1169-1180.
47. Teodorczyk M, Martin-Villalba A, (2010) Sensing invasion: cell surface receptors driving spreading of glioblastoma. J Cell Physiol 222: 1-10.